Korell, F., Schönland, S., Schmitt, A., Jansen, M., Farid, K., Müller-Tidow, C., . . . Hegenbart, U. (2023). First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma. Biomarker Research, 11, . https://doi.org/10.1186/s40364-023-00532-2
Chicago Style (17th ed.) CitationKorell, Felix, Stefan Schönland, Anita Schmitt, Madelaine Jansen, Kiavasch Farid, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, and Ute Hegenbart. "First Third-generation CAR T Cell Application Targeting CD19 for the Treatment of Systemic IgM AL Amyloidosis with Underlying Marginal Zone Lymphoma." Biomarker Research 11 (2023). https://doi.org/10.1186/s40364-023-00532-2.
MLA (9th ed.) CitationKorell, Felix, et al. "First Third-generation CAR T Cell Application Targeting CD19 for the Treatment of Systemic IgM AL Amyloidosis with Underlying Marginal Zone Lymphoma." Biomarker Research, vol. 11, 2023, https://doi.org/10.1186/s40364-023-00532-2.